设为首页 加入收藏

TOP

Cystadane (betaine anhydrous for oral solution)(六)
2013-10-12 13:42:27 来源: 作者: 【 】 浏览:4098次 评论:0
bsp;  RDT C PI003

Cystadane
betaine powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:66621-4000
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
betaine (betaine) betaine 6 g
Product Characteristics
Color white (none) Score     
Shape  Size 
Flavor  Imprint Code 
Contains         
Packaging
Item Code Package Description
1 NDC:66621-4000-1 180 POWDER, FOR SOLUTION (SCOOPFUL) in 1 BOTTLE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA020576 10/25/1996 
Labeler - Rare Disease Therapeutics, Inc. (966133100)
Registrant - Rare Disease Therapeutics, Inc. (966133100)
Establishment
Name Address ID/FEI Operations
Rare Disease Therapeutics, Inc.  966133100 label
Establishment
Name Address ID/FEI Operations
Orphan Europe, SARL  767598352 manufacture

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 3 4 5 6 下一页 尾页 6/6/6
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇cystadane(betaine, anhydrous) p.. 下一篇Erbitux (cetuximab)

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位